Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 23, 2017

DrugPatentWatch Database Preview

CHLORDIAZEPOXIDE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Chlordiazepoxide Hydrochloride, and what generic alternatives are available?

Chlordiazepoxide Hydrochloride is a drug marketed by Hikma Pharms Llc, Roxane, Mylan, Teva, Vangard, Ascot, Impax Labs, Barr, Mast Mm, Ferrante, Sandoz, Usl Pharma, Lederle, Pioneer Pharms, Halsey, Purepac Pharm, Ivax Sub Teva Pharms, Upsher-smith Labs, Parke Davis, Watson Labs, and Superpharm. and is included in sixty-four NDAs.

The generic ingredient in CHLORDIAZEPOXIDE HYDROCHLORIDE is chlordiazepoxide hydrochloride. There are eight drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the chlordiazepoxide hydrochloride profile page.

Summary for Tradename: CHLORDIAZEPOXIDE HYDROCHLORIDE

Patents:0
Applicants:21
NDAs:64
Suppliers / Packagers: see list13
Bulk Api Vendors: see list17
Clinical Trials: see list989
Patent Applications: see list1,701
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CHLORDIAZEPOXIDE HYDROCHLORIDE at DailyMed

Pharmacology for Tradename: CHLORDIAZEPOXIDE HYDROCHLORIDE

Ingredient-typeBenzodiazepines
Drug ClassBenzodiazepine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purepac Pharm
CHLORDIAZEPOXIDE HYDROCHLORIDE
chlordiazepoxide hydrochloride
CAPSULE;ORAL085155-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Halsey
CHLORDIAZEPOXIDE HYDROCHLORIDE
chlordiazepoxide hydrochloride
CAPSULE;ORAL085339-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Upsher-smith Labs
CHLORDIAZEPOXIDE HYDROCHLORIDE
chlordiazepoxide hydrochloride
CAPSULE;ORAL084678-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Lederle
CHLORDIAZEPOXIDE HYDROCHLORIDE
chlordiazepoxide hydrochloride
CAPSULE;ORAL086893-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Barr
CHLORDIAZEPOXIDE HYDROCHLORIDE
chlordiazepoxide hydrochloride
CAPSULE;ORAL084768-001Approved Prior to Jan 1, 1982ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Find generic sources and suppliers
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot